Economic Impact of Immune Tolerance Induction (ITI) with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Compared to Conventional Recombinant Factor VIII (rFVIII)

被引：0
|
作者：
Li, Nanxin [1 ]
Wilson, Koo [2 ]
Botteman, Marc [3 ]
Nicoloso, Daniel [3 ]
Krishnan, Sangeeta [1 ]
Su, Jun [1 ]
机构：
[1] Bioverativ, Waltham, MA USA
[2] Swedish Orphan Biovitrum SOBI, Stockholm, Sweden
[3] Pharmerit Int, Bathesda, MD USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-114993
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3520
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Recombinant factor VIII Fc fusion protein drives regulatory macrophage polarization
    Kis-Toth, Katalin
    Rajani, Gaurav Manohar
    Simpson, Allison
    Henry, Kate L.
    Dumont, Jennifer
    Peters, Robert T.
    Salas, Joe
    Loh, Christine
    BLOOD ADVANCES, 2018, 2 (21) : 2904 - 2916
  • [32] Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study
    Malec, Lynn
    Van Damme, An
    Chan, Anthony K. C.
    Spasova, Mariya
    Jain, Nisha
    Sensinger, Charlotte
    Dumont, Jennifer
    Lethagen, Stefan
    Carcao, Manuel
    Peyvandi, Flora
    BLOOD, 2023, 141 (16) : 1982 - 1989
  • [33] Population pharmacokinetic analysis of long-lasting recombinant factor VIII Fc fusion protein (rFVIIIFc) in patients with severe haemophilia A
    Neelakantan, S.
    Li, S.
    Powell, J.
    Josephson, N.
    Pasi, J.
    Perry, D.
    Shapiro, A. D.
    Ragni, M.
    Kulkarni, R.
    Fogarty, P.
    Brennan, A.
    Pierce, G.
    Jiang, H.
    Nestorov, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 354 - 355
  • [34] Perioperative Management Of Subjects With Haemophilia A In The ASPIRE Study With Long-acting Recombinant Factor VIII FC Fusion Protein (rFVIIIFc)
    Mahlangu, J.
    Ragni, M.
    Gupta, N.
    Rangarajan, S.
    Nogami, K.
    Li, X.
    Allen, G.
    Pierce, G. F.
    Robinson, B.
    HAEMOPHILIA, 2015, 21 : 82 - 82
  • [35] Study design for reitirate - a prospective study of rescue ITI with recombinant factor VIII Fc (rFVIIIFc) in patients who have failed previous ITI attempts
    Konigs, C.
    Meeks, S.
    Jain, N.
    Lethagen, S.
    HAEMOPHILIA, 2018, 24 : 66 - 66
  • [36] The structural basis for the functional comparability of factor VIII and the long-acting variant recombinant factor VIII Fc fusion protein
    Leksa, N. C.
    Chiu, P. -L.
    Bou-Assaf, G. M.
    Quan, C.
    Liu, Z.
    Goodman, A. B.
    Chambers, M. G.
    Tsutakawa, S. E.
    Hammel, M.
    Peters, R. T.
    Walz, T.
    Kulman, J. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (06) : 1167 - 1179
  • [37] Immune tolerance induction with a recombinant factor VIII Fc in haemophilia A: Final data from a chart review study
    Klamroth, R.
    Saleh, M. A.
    Glosli, H.
    Schiavulli, M.
    Guillet, B.
    Bystricka, L.
    Schoenstein, A.
    Lethagen, S.
    HAEMOPHILIA, 2024, 30 : 85 - 86
  • [38] Recombinant factor VIII Fc for the treatment of haemophilia A
    Hermans, Cedric
    Mancuso, Maria Elisa
    Nolan, Beatrice
    Pasi, K. John
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (06) : 745 - 761
  • [39] CLINICAL DEVELOPMENT OF RECOMBINANT FACTOR-VIII (RFVIII, KOGENATE)
    HURST, D
    HAEMOPHILIA, 1995, 1 : 26 - 28
  • [40] Factor VIII light chain domains of recombinant Factor VIII Fc fusion protein impact Fc effector function and CD16+NK cell activation
    Golding, Basil
    Lagasse, Daniel
    Sauna, Zuben
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
12345